[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558941":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":20,"responsibleParty":38,"collaborators":10,"id":42,"slug":10,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":10,"enrollmentInfo":50,"targetDuration":10,"studyType":53,"phases":10,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":69},{"fullName":5,"class":6},"Taichung Veterans General Hospital","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Cancer treatment with immunomodulator",null,"CRC patients had previously received cancer therapies along with immunomodulator",{"label":13,"type":10,"description":14,"interventionNames":10},"Cancer treatment without immunomodulator","CRC patients had previously received cancer therapies without immunomodulator",[16],{"name":17,"role":18,"phone":10,"phoneExt":10,"email":19},"Chou-Chen Chen, M.D.","CONTACT","ccchen24615237@gmail.com",[21,33],{"facility":22,"status":23,"city":24,"state":10,"zip":10,"country":25,"countryCode":26,"cosmosGeoPoint":27,"geoPoint":32,"contacts":10},"Chung-Shan Medical University Hospital","NOT_YET_RECRUITING","Taichung","Taiwan","TW",{"type":28,"coordinates":29},"Point",[30,31],120.6839,24.1469,{"lat":31,"lon":30},{"facility":5,"status":34,"city":24,"state":10,"zip":10,"country":25,"countryCode":26,"cosmosGeoPoint":35,"geoPoint":37,"contacts":10},"RECRUITING",{"type":28,"coordinates":36},[30,31],{"lat":31,"lon":30},{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Chou-Chen Chen","Attending Physician","100558941",false,"NCT06557668","Clinical Outcomes of Treatment With Immunomodulator Plus Cancer Therapies for Patients With Colorectal Cancer","Clinical Outcomes of Treatment With Immunomodulator Plus Standard Anti-cancer Therapies for Patients With Colorectal Cancer: A Retrospective Study","Inclusion Criteria:\n\n* Aged 20 years and older.\n* Patients who have been given a diagnosis of colorectal cancer.\n* Patients had previously initiated anti-cancer therapies between January 1, 2020, and Apr 30, 2024.\n\nExclusion Criteria:\n\n* None","ALL","20 Years",{"count":51,"type":52},250,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the survival and treatment outcomes among colorectal cancer patients undergoing anti-cancer treatment, both with and without an immunomodulator.",[56],"Colorectal Cancer",[56,58,59],"Astragalus Polysaccharides","Survival","2026-01-27",{"date":62,"type":63},"2026-01-29","ACTUAL",{"date":65,"type":63},"2024-08-20",{"date":67,"type":52},"2026-07",{"name":5,"class":6},2]